Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cellzome Receives Ortho-McNeil Milestone for AD Program | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Cellzome Receives Ortho-McNeil Milestone for AD Program

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cellzome, Inc. has received the first milestone payment from Ortho-McNeil Pharmaceutical, Inc. for its Gamma Secretase Modulator (GSM) program in connection with the selection of a lead compound by Ortho-McNeil. The two companies entered into a collaboration and license agreement in May 2005 and it was extended for a further year in January 2007.

Tim Edwards, Cellzome’s chief executive officer, said, “I am delighted with the progress we have made in our collaboration. This milestone payment is a reflection of the continued productivity of Cellzome’s drug discovery group in working with our collaborator to advance toward preclinical development a potential oral therapeutic for patients with Alzheimer’s disease, and further demonstrates the utility of our leading chemical proteomics technology.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics